Concepedia

Author

Madhavi Bandi

Harvard UniversityORCID

Also Known As

Madhavi Bandi, Madhavi L Bandi, Madhavi L. Bandi

95

Publications

3.6K

Citations

15

H-Index

15

Concepts

All Affiliations

Harvard UniversityDana-Farber Cancer InstituteThe University of Texas MD Anderson Cancer CenterVA Boston Healthcare SystemMassachusetts General Hospital
MB

About

Madhavi Bandi is an author at Harvard University specializing in medicine, tumor microenvironment, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

2.3K

2

Cell Biology

2

2

1.3K

3

Immunology

1

1

289

4

Pharmacology

1

1

903

5

Autoimmunity

1

1

289

Madhavi Bandi

×

16

Publications

3.6K

Citations

15

H-Index

YearCitations

Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells

Takeshi Fujiwara, Madhavi Bandi, Masayuki Nitta,

Nature

2005

1.1K

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina, Yuting Sun, Marina Protopopova,

Nature Medicine

2018

903

Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target

Dharminder Chauhan, Ajita Singh, Mohan Brahmandam,

Cancer Cell

2009

289

A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma

Güllü Görgün, Elisabetta Calabrese, Teru Hideshima,

Blood

2010

271

Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma

Güllü Görgün, Elisabetta Calabrese, Ender Soydan,

Blood

2010

228

A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma

Dharminder Chauhan, Ajita Singh, Monette Aujay,

Blood

2010

216

PR‐924, a selective inhibitor of the immunoproteasome subunit LMP‐7, blocks multiple myeloma cell growth both <i>in vitro</i> and <i>in vivo</i>

Ajita Singh, Madhavi Bandi, Monette Aujay,

British Journal of Haematology

2010

112

A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cells

Ajita Singh, Madhavi Bandi, Noopur Raje,

Blood

2011

82

Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells

Dharminder Chauhan, Madhavi Bandi, Ajita Singh,

British Journal of Haematology

2011

73

Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation

Yuting Sun, Madhavi Bandi, Timothy Lofton,

Cell Reports

2019

67

Page 1